Characterization of Acinetobacter baumannii from intensive care units and home care patients in Palermo, Italy

Clinical Microbiology and Infection

Volumn 17, Issue 11, 2011, Pages

  Mammina, C ^a   Bonura, C ^a   Aleo, A ^a   Cala C ^a   Caputo, G ^b   Cataldo, M C ^b   Benedetto, A Di ^c   Distefano, S ^a   Fasciana, T ^a   Labisi, M ^c   Sodano, C ^d   Palma, D M ^d   Giammanco, A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Local Health Agency   (Italy)

^c Ospedale GF Ingrassia   (Italy)

^d Di Cristina and Benfratelli'   (Italy)

Author keywords

Acinetobacter baumannii; Epidemiology; Home care; Intensive care unit; Multidrug resistance

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; COLISTIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DECUBITUS; HOME CARE; INTENSIVE CARE UNIT; ITALY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL;

ACINETOBACTER BAUMANNII;

EID: 80054079069     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03654.x     Document Type: Article

References (18)

1. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 233-238.
2. De Medina T, Carmeli Y. The pivotal role of long-term care facilities in the epidemiology of Acinetobacter baumannii: another brick in the wall. Clin Infect Dis 2010; 15: 50.
3. McGoldrick M, Rhinehart E. Managing multidrug-resistant organisms in home care and hospice: surveillance, prevention, and control. Home Healthc Nurse 2007; 25: 580-586.
4. Rhinehart E. Infection control in home care. Emerg Infect Dis 2001; 7: 208-211.
5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, vol. 30, no. 1. Twentieth informational supplement M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute, 2010.
6. Woodford N, Ellington MJ, Coelho JM et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2006; 27: 351-353.
7. Higgins PG, Lehmann M, Seifert H. Inclusion of OXA-143 primers in a multiplex polymerase chain reaction (PCR) for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 2010; 35: 305.
8. D'Arezzo S, Capone A, Petrosillo N et al. Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect 2009; 15: 347-357.
9. Turton JF, Gabriel SN, Valderrey C, Kaufmann ME, Pitt TL. Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 2007; 13: 807-815.
10. Tsakris A, Ikonomidis A, Poulou A et al. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect 2008; 14: 588-594.
11. Bratu S, Landman D, Martin DA, Georgescu C, Quale J. Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York City. Antimicrob Agents Chemother 2008; 52: 2999-3005.
12. Towner KJ, Levi K, Vlassiadi M. Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin Microbiol Infect 2008; 14: 161-167.
13. Giannouli M, Cuccurullo S, Crivaro V et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol 2010; 48: 1223-1230.
14. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS ONE 2010; 5: e10034.
15. Mezzatesta ML, D'Andrea MM, Migliavacca R et al. Epidemiological characterization and distribution of carbapenem resistant Acinetobacter baumannii clinical isolates in Italy. Clin Microbiol Infect 2011; Apr 4. doi: [Epub ahead of print].
16. Carretto E, Barbarini D, Dijkshoorn L et al. on behalf of the APSI Acinetobacter Study Group. Widespread carbapenem resistant Acinetobacter baumannii clones in Italian hospitals revealed by a multicenter study. Infect Genet Evol. 2011; 11: 1319-1326.
17. Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis 2010; 23: 332-339.
18. Di Popolo A, Giannouli M, Triassi M, Brisse S, Zarrilli R. Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin Microbiol Infect 2011; 17: 197-201.